N-[3-(1,3-benzothiazol-2-yl)-4,5,6,7-tetrahydro-1-benzothiophen-2-yl]-5-chlorothiophene-2-carboxamide结构式
|
常用名 | N-[3-(1,3-benzothiazol-2-yl)-4,5,6,7-tetrahydro-1-benzothiophen-2-yl]-5-chlorothiophene-2-carboxamide | 英文名 | N-[3-(1,3-benzothiazol-2-yl)-4,5,6,7-tetrahydro-1-benzothiophen-2-yl]-5-chlorothiophene-2-carboxamide |
|---|---|---|---|---|
| CAS号 | 325988-46-3 | 分子量 | 431.0 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C20H15ClN2OS3 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 英文名 | N-[3-(1,3-benzothiazol-2-yl)-4,5,6,7-tetrahydro-1-benzothiophen-2-yl]-5-chlorothiophene-2-carboxamide |
|---|
| 分子式 | C20H15ClN2OS3 |
|---|---|
| 分子量 | 431.0 |
| InChIKey | KXKVWRFGUHZSCS-UHFFFAOYSA-N |
| SMILES | C1CCC2=C(C1)C(=C(S2)NC(=O)C3=CC=C(S3)Cl)C4=NC5=CC=CC=C5S4 |
|
实验名称:High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i ...
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
External Id:HMS1303
|